Company Update (NYSE:JNJ): Johnson & Johnson gets $1.2 billion Arkansas Risperdal judgment tossed out

[Reuters] – Johnson & Johnson on Thursday won a reversal by the Arkansas Supreme Court of a $1.2 billion judgment imposed after a jury concluded that the drugmaker improperly marketed its anti-psychotic drug . . . → Read More: Company Update (NYSE:JNJ): Johnson & Johnson gets $1.2 billion Arkansas Risperdal judgment tossed out Similar Articles: Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results Merck & Co. Inc. (NYSE:MRK) – Keep an Eye on Biogen, Johnson & Johnson, and Merck Today Merck & Co. Inc. (NYSE:MRK) – Keep An Eye On GW, Johnson & Johnson, Durata, and Merck Today